These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18543134)

  • 1. Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.
    Omloo JM; Sloof GW; Boellaard R; Hoekstra OS; Jager PL; van Dullemen HM; Fockens P; Plukker JT; van Lanschot JJ
    Endoscopy; 2008 Jun; 40(6):464-71. PubMed ID: 18543134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
    J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer.
    Flamen P; Lerut A; Van Cutsem E; Cambier JP; Maes A; De Wever W; Peeters M; De Leyn P; Van Raemdonck D; Mortelmans L
    J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1085-92. PubMed ID: 11088030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric GIST malignancy evaluated by 18FDG-PET as compared with EUS-FNA and endoscopic biopsy.
    Yamada M; Niwa Y; Matsuura T; Miyahara R; Ohashi A; Maeda O; Ando T; Ohmiya N; Itoh A; Hirooka Y; Goto H
    Scand J Gastroenterol; 2007 May; 42(5):633-41. PubMed ID: 17454885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is positron emission tomography useful in locoregional staging of esophageal cancer? Results of a multidisciplinary initiative comparing CT, positron emission tomography, and EUS.
    Sandha GS; Severin D; Postema E; McEwan A; Stewart K
    Gastrointest Endosc; 2008 Mar; 67(3):402-9. PubMed ID: 18178202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
    Vesselle H; Freeman JD; Wiens L; Stern J; Nguyen HQ; Hawes SE; Bastian P; Salskov A; Vallières E; Wood DE
    Clin Cancer Res; 2007 Jun; 13(11):3255-63. PubMed ID: 17545531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer.
    Sasaki R; Komaki R; Macapinlac H; Erasmus J; Allen P; Forster K; Putnam JB; Herbst RS; Moran CA; Podoloff DA; Roth JA; Cox JD
    J Clin Oncol; 2005 Feb; 23(6):1136-43. PubMed ID: 15718309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
    Kim SY; Roh JL; Kim MR; Kim JS; Choi SH; Nam SY; Lee SW; Kim SB
    J Nucl Med; 2007 May; 48(5):752-7. PubMed ID: 17475963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer.
    Machtay M; Natwa M; Andrel J; Hyslop T; Anne PR; Lavarino J; Intenzo CM; Keane W
    Head Neck; 2009 Feb; 31(2):195-201. PubMed ID: 19107945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
    McDonough PB; Jones DR; Shen KR; Northup PG; Galysh RL; Hernandez A; White GE; Kahaleh M; Shami VM
    Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
    Gallamini A; Rigacci L; Merli F; Nassi L; Bosi A; Capodanno I; Luminari S; Vitolo U; Sancetta R; Iannitto E; Trentin L; Stelitano C; Tavera S; Biggi A; Castagnoli A; Versari A; Gregianin M; Pelosi E; Torchio P; Levis A
    Haematologica; 2006 Apr; 91(4):475-81. PubMed ID: 16585014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.
    Murthy SB; Patnana SV; Xiao L; Rohren E; Hofstetter WL; Swisher SG; Liao Z; Lee JH; Bhutani MS; Macapinlac HA; Wang X; Ajani JA
    Oncology; 2010; 78(5-6):316-22. PubMed ID: 20699623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
    Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
    J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
    Pech O; May A; Günter E; Gossner L; Ell C
    Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
    J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer.
    Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R
    Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.